about
Antigen-based immunotherapy for autoimmune disease: current statusOrgan-specific and memory treg cells: specificity, development, function, and maintenanceUse of a High-Density Protein Microarray to Identify Autoantibodies in Subjects with Type 2 Diabetes Mellitus and an HLA Background Associated with Reduced Insulin SecretionType 1 diabetes mellitus.Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes riskThe Clinical Course of Patients with Preschool Manifestation of Type 1 Diabetes Is Independent of the HLA DR-DQ GenotypeThe pancreatic β-cell transcriptome and integrated-omics.ZnT8-reactive T cells are weakly pathogenic in NOD mice but can participate in diabetes under inflammatory conditionsThe role of dendritic cells in tissue-specific autoimmunity.Combination of an Antigen-Specific Therapy and an Immunomodulatory Treatment to Simultaneous Block Recurrent Autoimmunity and Alloreactivity in Non-Obese Diabetic Mice.Adiponectin-SOGA Dissociation in Type 1 Diabetes.Making the most of major histocompatibility complex molecule multimers: applications in type 1 diabetes.β-cell-specific CD8 T cell phenotype in type 1 diabetes reflects chronic autoantigen exposure.Discovery of Phosphorylated Peripherin as a Major Humoral Autoantigen in Type 1 Diabetes Mellitus.Can we vaccinate against Type 1 diabetes?Non-HLA type 1 diabetes genes modulate disease risk together with HLA-DQ and islet autoantibodies.Enhanced Direct Major Histocompatibility Complex Class I Self-Antigen Presentation Induced by Chlamydia InfectionBlood-based signatures in type 1 diabetes.Expression-Based Genome-Wide Association Study Links Vitamin D-Binding Protein With Autoantigenicity in Type 1 Diabetes.Novel autoantigens in type 1 diabetes.Obstacles and opportunities for targeting the effector T cell response in type 1 diabetes.Pathogenic mechanisms in type 1 diabetes: the islet is both target and driver of disease.Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcomePatterns of β-cell autoantibody appearance and genetic associations during the first years of life.A Combinatorial Protein Microarray for Probing Materials Interaction with Pancreatic Islet Cell PopulationsTissue distribution and clonal diversity of the T and B cell repertoire in type 1 diabetesStaging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association.Immunological pathways to β-cell damage in Type 1 diabetes.Structural Characteristics of HLA-DQ that May Impact DM Editing and Susceptibility to Type-1 Diabetes.Antigen-specific therapy against type 1 diabetes: mechanisms and perspectives.Self-antigen presentation by dendritic cells in autoimmunity.Type 1 diabetes associated HLA-DQ2 and DQ8 molecules are relatively resistant to HLA-DM mediated release of invariant chain-derived CLIP peptidesParacrine co-delivery of TGF-β and IL-2 using CD4-targeted nanoparticles for induction and maintenance of regulatory T cells.JDRF's vision and strategy for prevention of type 1 diabetes.Selective immunotargeting of diabetogenic CD4 T cells by genetically redirected T cells.Tolerogenic nanoparticles inhibit T cell-mediated autoimmunity through SOCS2.Autoantibodies against PFDN2 are associated with an increased risk of type 2 diabetes: A case-control study.Characterization of the autoimmune response against the nerve tissue S100β in patients with type 1 diabetes.T Cell Receptor Profiling in Type 1 Diabetes.Coupling of Insulin Secretion and Display of a Granule-resident Zinc Transporter ZnT8 on the Surface of Pancreatic Beta Cells.
P2860
Q26852915-E616B2D8-6F4B-42A3-9372-5FCF303F488BQ27010198-72C90085-F2EF-433F-AB6B-CC8E65B7BAA9Q28551169-3E7CF2F5-58DD-4814-AD1E-855EF6151AB7Q30235021-60D3B0F3-5679-4740-8EFA-42027B9DE7A9Q30279028-B7A29A9C-37FA-42E5-B24F-C41073AC6B60Q33737477-1582B579-1D9F-4F30-8FE3-D11B7EF3B79CQ33855031-D21FDBC5-786F-481F-8C01-0581CCBC6548Q34227916-BD65805B-E002-4C50-9809-EB3604098399Q34422017-7B44DFCC-B97E-4830-9278-A6F3E08889FBQ35665104-EDEF04C2-B076-4BFB-9F39-052520F1A65AQ35916487-353AEEE8-A978-4BD8-AADF-A7AB4A8CD720Q36010973-4A93F7D3-865C-4767-B227-8BBEE0C77921Q36019335-41C0CEE3-E920-44A0-B7CF-C9639F8C460DQ36019487-7DF862D5-B7E1-46AB-8355-35C8E6C1C4DFQ36296386-6FD3B359-3283-49EA-85BC-DC17A9748F7FQ36348307-517F213D-E9AF-450A-AC41-C50DD4FC9904Q36513486-4C83BADF-7C78-4D39-8C71-8DC07B8E8BC8Q36552481-AF49F26B-C109-464B-A90E-A0AC8B815E2EQ36820754-2B07853F-4532-40D3-8888-20AEB4B90CC6Q36881807-24790907-7E4B-4BA4-9FCE-171598964273Q36995345-55A69EC0-2DA0-421F-8E30-A75DC77AB965Q37088180-12E70B1C-1B73-4B2A-A683-C4EAB11582D7Q37088225-4D54646D-AA87-4AAB-A07D-8FB965EB915EQ37193363-1F9848F8-00F7-46E9-BCAE-F2E8BF94B60CQ37293779-54F3CEB4-9784-48C7-8D9B-51622E474922Q37469208-5928A306-4673-4923-BED9-2AA48C0D8FEEQ37659402-07E8AFCB-FF3E-4695-AA6F-153BF7C66D23Q38063940-4824E691-D86A-43E0-9A12-2B1AB377FCCFQ38134730-DD2B50B7-D92B-4534-9C01-0624BAC42158Q38184646-FE53C93C-EF52-45F1-935C-0D22EA67250CQ38193091-96D67947-A6EA-44E5-940F-C2EA77E62884Q38808868-2748B512-6FB8-428A-AEFE-07A30F41458FQ38874906-DA6E852F-C0C3-4591-AF12-CCF2A5D40D80Q38895435-897B7160-3E01-4074-9E9C-7D34FF8F8A92Q38983184-BDA3E3C2-D121-4671-97BB-C1D189A0D989Q39665315-82EFD5E0-F657-4EE7-9975-5CB209F908D8Q40113555-33748F78-8B2B-46D9-830D-78A03B34F5EDQ41680619-CE6FC5DA-A0CE-4DDD-83CE-A022F57D2871Q42374922-04AB7E5B-6381-413E-ACA0-C746E58C255BQ42504848-575FDCF8-194A-4C35-B16C-55B3F0182170
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Antigen targets of type 1 diabetes autoimmunity
@ast
Antigen targets of type 1 diabetes autoimmunity
@en
type
label
Antigen targets of type 1 diabetes autoimmunity
@ast
Antigen targets of type 1 diabetes autoimmunity
@en
prefLabel
Antigen targets of type 1 diabetes autoimmunity
@ast
Antigen targets of type 1 diabetes autoimmunity
@en
P2860
P1476
Antigen targets of type 1 diabetes autoimmunity
@en
P2093
Bart O Roep
P2860
P304
P356
10.1101/CSHPERSPECT.A007781
P50
P577
2012-04-01T00:00:00Z